{
  "id": [
    "32155165"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32155165"
  ],
  "pmcid": [
    "PMC7064180"
  ],
  "doi": [
    "10.1371/journal.pone.0229239"
  ],
  "title": [
    "Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria."
  ],
  "authorString": [
    "Schmidbauer C, Schubert R, Schütz A, Schwanke C, Luhn J, Gutic E, Pirker R, Lang T, Reiberger T, Haltmayer H, Gschwantler M."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Schmidbauer C"
          ],
          "firstName": [
            "Caroline"
          ],
          "lastName": [
            "Schmidbauer"
          ],
          "initials": [
            "C"
          ],
          "authorId": [
            {
              "_": "0000-0001-7762-7483",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria.",
                "Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.",
                "Vienna HIV & Liver Study Group, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Schubert R"
          ],
          "firstName": [
            "Raphael"
          ],
          "lastName": [
            "Schubert"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ambulatorium Suchthilfe Wien, Suchthilfe Wien gGmbH, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Schütz A"
          ],
          "firstName": [
            "Angelika"
          ],
          "lastName": [
            "Schütz"
          ],
          "initials": [
            "A"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ambulatorium Suchthilfe Wien, Suchthilfe Wien gGmbH, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Schwanke C"
          ],
          "firstName": [
            "Cornelia"
          ],
          "lastName": [
            "Schwanke"
          ],
          "initials": [
            "C"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ambulatorium Suchthilfe Wien, Suchthilfe Wien gGmbH, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Luhn J"
          ],
          "firstName": [
            "Julian"
          ],
          "lastName": [
            "Luhn"
          ],
          "initials": [
            "J"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ambulatorium Suchthilfe Wien, Suchthilfe Wien gGmbH, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Gutic E"
          ],
          "firstName": [
            "Enisa"
          ],
          "lastName": [
            "Gutic"
          ],
          "initials": [
            "E"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Pirker R"
          ],
          "firstName": [
            "Roxana"
          ],
          "lastName": [
            "Pirker"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Lang T"
          ],
          "firstName": [
            "Tobias"
          ],
          "lastName": [
            "Lang"
          ],
          "initials": [
            "T"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Reiberger T"
          ],
          "firstName": [
            "Thomas"
          ],
          "lastName": [
            "Reiberger"
          ],
          "initials": [
            "T"
          ],
          "authorId": [
            {
              "_": "0000-0002-4590-3583",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.",
                "Vienna HIV & Liver Study Group, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Haltmayer H"
          ],
          "firstName": [
            "Hans"
          ],
          "lastName": [
            "Haltmayer"
          ],
          "initials": [
            "H"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ambulatorium Suchthilfe Wien, Suchthilfe Wien gGmbH, Vienna, Austria."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Gschwantler M"
          ],
          "firstName": [
            "Michael"
          ],
          "lastName": [
            "Gschwantler"
          ],
          "initials": [
            "M"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria.",
                "Sigmund Freud University, Vienna, Austria."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-7762-7483",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-4590-3583",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data",
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "3"
      ],
      "volume": [
        "15"
      ],
      "journalIssueId": [
        "2918449"
      ],
      "dateOfPublication": [
        "2020 "
      ],
      "monthOfPublication": [
        "0"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-01-01"
      ],
      "journal": [
        {
          "title": [
            "PloS one"
          ],
          "ISOAbbreviation": [
            "PLoS ONE"
          ],
          "medlineAbbreviation": [
            "PLoS One"
          ],
          "NLMid": [
            "101285081"
          ],
          "ISSN": [
            "1932-6203"
          ],
          "ESSN": [
            "1932-6203"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "e0229239"
  ],
  "abstractText": [
    "BACKGROUND:Directly acting antivirals (DAA) against hepatitis C virus (HCV) infection have facilitated sustained virologic response (SVR) rates >90% in clinical studies. Yet, real life data regarding DAA treatment in people who inject drugs (PWIDs) are scarce. We evaluated the effectiveness of glecaprevir/pibrentasvir (G/P) in difficult-to-treat PWIDs with presumed high risk of non-adherence to DAA therapy using the concept of directly observed therapy involving their opioid substitution therapy (OST) facility. METHODS:N = 145 patients (m/f: 91/54; median age: 41.1 (IQR 19.5) years; HCV-genotype (GT) 1/2/3/4: 82/1/56/5, GT3: 38.6%; cirrhosis: n = 6; 4.1%) treated with G/P were included. PWIDs at high risk for non-adherence to DAA therapy received HCV treatment together with their OST under the supervision of medical staff (\"directly observed therapy\", DOT). The effectiveness of G/P given as DOT in PWIDs with presumed high risk of non-adherence to DAA therapy was compared to patients with suspected \"excellent compliance\" in the \"standard setting\" (SS) of G/P prescription at a tertiary care center and self-managed G/P intake at home. Treatment duration was 8-16 weeks according to the G/P drug label. RESULTS:DOT-patients (n = 74/145; 51.0%) were younger than SS-patients (median 38.7, IQR 12.5 vs. median 50.6, IQR 20.3 years), all had psychiatric co-morbidities and most had a poor socioeconomic status. 50/74 (67.6%) reported ongoing intravenous drug use (IDU). SVR was achieved in n = 70/74 (94.6%) patients with n = 3 being lost to follow-up (FU) and n = 1 showing nonresponse to therapy. SS-patients achieved SVR in 97.2% (69/71) with n = 1 patient being lost to FU and n = 1 patient with GT3 showing HCV relapse. CONCLUSION:G/P given as DOT along with OST in PWIDs with high risk of non-adherence to DAA therapy resulted in similarly high SVR rates (94.6%) as in patients with presumed \"excellent compliance\" under standard drug intake."
  ],
  "affiliation": [
    "Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic-eCollection"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Comparative Study",
        "Research Support, Non-U.S. Gov't",
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hepatitis C, Chronic"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Substance Abuse, Intravenous"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Sulfonamides"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pyrrolidines"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Benzimidazoles"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Quinoxalines"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Combinations"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Treatment Outcome"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Directly Observed Therapy"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Patient Compliance"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Social Class"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Austria"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Medication Adherence"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Young Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Opiate Substitution Treatment"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Sustained Virologic Response"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Sulfonamides"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Drug Combinations"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Quinoxalines"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Benzimidazoles"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Pyrrolidines"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "glecaprevir and pibrentasvir"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1371/journal.pone.0229239"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7064180"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7064180?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1371/journal.pone.0229239"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-06-15"
  ],
  "dateOfCreation": [
    "2020-03-11"
  ],
  "firstIndexDate": [
    "2020-03-12"
  ],
  "fullTextReceivedDate": [
    "2020-03-24"
  ],
  "dateOfRevision": [
    "2020-06-15"
  ],
  "electronicPublicationDate": [
    "2020-03-10"
  ],
  "firstPublicationDate": [
    "2020-03-10"
  ]
}